Focus Advisor Solutions LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 166.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,626 shares of the medical equipment provider’s stock after purchasing an additional 6,009 shares during the quarter. Focus Advisor Solutions LLC’s holdings in Intuitive Surgical were worth $3,915,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of America Corp DE grew its position in Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $1,335,753,000. Amundi lifted its holdings in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after buying an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after buying an additional 184,044 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Shares of ISRG opened at $399.06 on Friday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock has a market cap of $138.33 billion, a PE ratio of 49.08, a price-to-earnings-growth ratio of 3.02 and a beta of 1.45. The firm has a fifty day moving average price of $423.51 and a 200 day moving average price of $427.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter last year, the company posted $2.40 earnings per share. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
Insider Activity
In related news, Director Craig Barratt sold 1,150 shares of the firm’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the transaction, the director owned 1,150 shares in the company, valued at $529,000. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the completion of the sale, the executive vice president owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. This trade represents a 6.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,363 shares of company stock worth $17,738,749 over the last ninety days. 0.60% of the stock is owned by corporate insiders.
Key Intuitive Surgical News
Investors following ISRG have been watching these news items:
- Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
- Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
- Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
Analyst Upgrades and Downgrades
ISRG has been the subject of several research analyst reports. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. Robert W. Baird upped their price target on Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Thursday, November 12th. Finally, UBS Group reissued a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $495.90.
View Our Latest Report on Intuitive Surgical
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Read More
- Five stocks we like better than Intuitive Surgical
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
